Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer

Background Gallbladder cancer (GBC) is usually detected in advanced stages with a low 5-year survival rate. Delta-like ligand 4 (DLL4), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-2alpha (HIF2α) have been studied for their role in tumorigenesis and potential for therapeut...

Full description

Bibliographic Details
Main Authors: Sujin Park, Junsik Kim, Woncheol Jang, Kyoung-Mee Kim, Kee-Taek Jang
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2023-03-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://jpatholtm.org/upload/pdf/jptm-2023-02-01.pdf
_version_ 1797867219932151808
author Sujin Park
Junsik Kim
Woncheol Jang
Kyoung-Mee Kim
Kee-Taek Jang
author_facet Sujin Park
Junsik Kim
Woncheol Jang
Kyoung-Mee Kim
Kee-Taek Jang
author_sort Sujin Park
collection DOAJ
description Background Gallbladder cancer (GBC) is usually detected in advanced stages with a low 5-year survival rate. Delta-like ligand 4 (DLL4), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-2alpha (HIF2α) have been studied for their role in tumorigenesis and potential for therapeutic target, and multiple clinical trials of the agents targeting them are ongoing. We investigated the expression of these markers in surgically resected GBC and tried to reveal their association with the clinicopathologic features, mutual correlation of their expression, and prognosis of the GBC patients by their expression. Methods We constructed the tissue microarray blocks of 99 surgically resected GBC specimens and performed immunohistochemistry of DLL4, VEGF, and HIF2α. We used the quantitative digital image analysis to evaluate DLL4 and VEGF expression, while the expression of HIF2α was scored manually. Results The expression of VEGF and HIF2α showed a significant trend with tumor differentiation (p = .028 and p = .006, respectively). We found that the high DLL4 and VEGF expression were significantly correlated with lymph node metastasis (p = .047, both). The expression of VEGF and HIF2α were significantly correlated (p < .001). The GBC patients with low HIF2α expression showed shorter recurrence-free survival than those with high HIF2α expression. Conclusions This study suggested the possibility of the usage of DLL4 and VEGF to predict the lymph node metastasis and the possibility of VEGF and HIF2α to predict the expression level mutually. Further studies may be needed to validate our study results and eventually accelerate the introduction of the targeted therapy in GBC.
first_indexed 2024-04-09T23:36:50Z
format Article
id doaj.art-007761423497425680dee7b6fed4a9da
institution Directory Open Access Journal
issn 2383-7837
2383-7845
language English
last_indexed 2024-04-09T23:36:50Z
publishDate 2023-03-01
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
record_format Article
series Journal of Pathology and Translational Medicine
spelling doaj.art-007761423497425680dee7b6fed4a9da2023-03-20T04:41:41ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452023-03-0157211312210.4132/jptm.2023.02.0117064Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancerSujin Park0Junsik Kim1Woncheol Jang2Kyoung-Mee Kim3Kee-Taek Jang4 Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Statistics, Duksung Women’s University, Seoul, Korea Department of Statistics, Duksung Women’s University, Seoul, Korea Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaBackground Gallbladder cancer (GBC) is usually detected in advanced stages with a low 5-year survival rate. Delta-like ligand 4 (DLL4), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-2alpha (HIF2α) have been studied for their role in tumorigenesis and potential for therapeutic target, and multiple clinical trials of the agents targeting them are ongoing. We investigated the expression of these markers in surgically resected GBC and tried to reveal their association with the clinicopathologic features, mutual correlation of their expression, and prognosis of the GBC patients by their expression. Methods We constructed the tissue microarray blocks of 99 surgically resected GBC specimens and performed immunohistochemistry of DLL4, VEGF, and HIF2α. We used the quantitative digital image analysis to evaluate DLL4 and VEGF expression, while the expression of HIF2α was scored manually. Results The expression of VEGF and HIF2α showed a significant trend with tumor differentiation (p = .028 and p = .006, respectively). We found that the high DLL4 and VEGF expression were significantly correlated with lymph node metastasis (p = .047, both). The expression of VEGF and HIF2α were significantly correlated (p < .001). The GBC patients with low HIF2α expression showed shorter recurrence-free survival than those with high HIF2α expression. Conclusions This study suggested the possibility of the usage of DLL4 and VEGF to predict the lymph node metastasis and the possibility of VEGF and HIF2α to predict the expression level mutually. Further studies may be needed to validate our study results and eventually accelerate the introduction of the targeted therapy in GBC.http://jpatholtm.org/upload/pdf/jptm-2023-02-01.pdfgallbladder neoplasmsdll4vascular endothelial growth factorhif2αtargeted therapy
spellingShingle Sujin Park
Junsik Kim
Woncheol Jang
Kyoung-Mee Kim
Kee-Taek Jang
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
Journal of Pathology and Translational Medicine
gallbladder neoplasms
dll4
vascular endothelial growth factor
hif2α
targeted therapy
title Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
title_full Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
title_fullStr Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
title_full_unstemmed Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
title_short Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
title_sort clinicopathologic significance of the delta like ligand 4 vascular endothelial growth factor and hypoxia inducible factor 2α in gallbladder cancer
topic gallbladder neoplasms
dll4
vascular endothelial growth factor
hif2α
targeted therapy
url http://jpatholtm.org/upload/pdf/jptm-2023-02-01.pdf
work_keys_str_mv AT sujinpark clinicopathologicsignificanceofthedeltalikeligand4vascularendothelialgrowthfactorandhypoxiainduciblefactor2aingallbladdercancer
AT junsikkim clinicopathologicsignificanceofthedeltalikeligand4vascularendothelialgrowthfactorandhypoxiainduciblefactor2aingallbladdercancer
AT woncheoljang clinicopathologicsignificanceofthedeltalikeligand4vascularendothelialgrowthfactorandhypoxiainduciblefactor2aingallbladdercancer
AT kyoungmeekim clinicopathologicsignificanceofthedeltalikeligand4vascularendothelialgrowthfactorandhypoxiainduciblefactor2aingallbladdercancer
AT keetaekjang clinicopathologicsignificanceofthedeltalikeligand4vascularendothelialgrowthfactorandhypoxiainduciblefactor2aingallbladdercancer